Acute liver failure (ALF) is a life-threatening disease caused by hepatocellular dysfunction and has high-mortality rates.
rejection, hiHeps represent an important in vitro cell source for BAL treatment. Previous studies have developed a hiHep-based BAL system (hiHep-BAL) for the treatment of porcine ALF, which indicated that BAL could be applied to clinical treatment because it attenuated liver damage, restored porcine liver function and prolonged survival. 5 However, for hiHeps to be used with a BAL for clinical treatment, several criteria need to be met including the generation of at least 10 10 functional hiHeps. Additionally, the expansion of these cells must be performed in a chemically defined SFM in vitro prior to clinical applications. 2, 6, 7 Currently, the culture and expansion of hiHeps are performed in hepatocyte maintenance medium (HMM) containing fetal bovine serum (FBS) in vitro. FBS has a considerable degree of interbatch variation and may cause infection and immunological responses following cell treatment. 7, 8 Therefore, serum-free strategies using exogenous growth factors have been used to achieve the clinical-scale production of cells, and these growth factors can be applied to regulate cell proliferation and function. 9, 10 Previously, we preliminarily screened a chemically defined serumfree medium (SFM) through Plackett-Burman design, 11 and then obtained a medium through initial optimization, named GCM14 medium, but it merely maintained hiHep growth and certain functions.
Therefore, it is necessary to add exogenous factors to further optimize the medium. As insulin is a peptide hormone having several different actions, not only on glucose metabolism, but also on regulating cell proliferation. [12] [13] [14] For example, in the liver, insulin can promote glycogen synthesis, lipid synthesis and protein production while turning off gluconeogenesis. 15, 16 In primary rat hepatocytes, a study showed that insulin is an important regulator of liver-specific cytochrome P450 gene expression, and the level of albumin mRNA expression was reduced when insulin was lacking. 17 In regard to regulating cell proliferation, a study revealed that insulin-stimulated goose liver cell mRNA and protein expression of genes involved in proliferation and promoted cell growth through the PI3K/AKT signalling pathway. 14, 18 Similarly, insulin can induce CARM1 up-regulation to facilitate rat primary hepatocyte proliferation and enhance cyclin-dependent kinase expression. 19 Although the results in the literature were sometimes inconsistent, 20, 21 in most instances, insulin was shown to promote the proliferation of different cell types. [22] [23] [24] [25] Thus, it has been demonstrated that insulin plays a crucial role in regulating cell proliferation and metabolism. However, the effect and mechanism of insulin on the proliferation and function of human hepatocytes, especially transdifferentiated cells, remain poorly understood.
In this study, the effects of insulin on the proliferation and function of hiHeps cultured in a defined SFM were investigated. We found that 1.0 mg/L insulin significantly promoted hiHep proliferation and maintained cell viability, and this pro-proliferation effect occurred via augmented cyclin D1 expression that was mediated by the Akt1/mTOR/p70S6K and Akt1/p53 pathways. Additionally, insulin stimulated the hiHep albumin synthesis and secretion, lipid synthesis, glucose uptake and glycogen synthesis in SFM. Finally, we found that insulin increased the protein expression of Albumin (ALB) and UDP-glucuronosyltransferase1A1 (UGT1A1) in hiHeps by affecting the level of HNF1A. These results provide a better understanding of how insulin affects transdifferentiated hiHeps, which has important implications for utilizing insulin to expand clinical-grade, functional hiHeps in vitro for use in BALs. The designed and initial optimized SFM was named GCM14 medium, which consisted of DMEM/F12 (Gibco, USA) basal culture medium supplemented with 10 ng/mL TGF-α (PeproTech, USA), 40 ng/ mL EGF (PeproTech, USA), 10 µmol/L DEX (Sigma-Aldrich, USA),
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tate (Solarbio, China) and 1.0 mg/L Vitamin E acetate (Solarbio, China).
| Cell proliferation assay
To assess the effect of insulin on cell proliferation, hiHeps were analysed using a cell counting kit-8 (CCK-8, DOJINDO, Japan) according to the manufacturer's instructions. Cell proliferation was expressed as a percentage relative to the proliferation of the non-treatment control, which was set to 100%. For each group, mean values of the absorbance from three wells were calculated.
| Flow cytometric analysis
hiHeps were cultured in 6-well plates at 1 × 10 6 cells/well in GCM14 medium supplemented with or without 1.0 mg/L insulin. After 4 days, the cells were harvested and centrifuged at 800 rpm and 4°C
for 5 minutes, washed with cold PBS twice and fixed in precooled 70% ethanol at 4°C overnight. After fixation, the cells were washed three times with PBS, resuspended in 500 μL PBS containing 1 μL Triton X-100 for 30 minutes at room temperature, and then treated with 1 mL of the cell cycle staining reagent propidium iodide (PI, Sigma-Aldrich, USA) for 30 minutes in the dark. Subsequently, the cell cycle distribution was analysed using a flow cytometer, and the percentage of cells in each phase of the cell cycle was determined using FlowJo software. Three independent biological replicates were performed for each experimental group.
| Albumin and urea analysis
During cell culture, the supernatant of the medium was collected every two days. The urea concentration in the supernatant was measured using a BUN kit (Nanjing Jiancheng Bioengineering Institute, China), and albumin secreted by hiHeps was measured with a human albumin enzyme-linked immunosorbent assay kit (Elisa, Bethyl, USA) according to the manufacturer's instructions.
| Immunofluorescence staining
Immunohistochemistry was performed as described previously.
Briefly were stained with DAPI (Invitrogen, USA) for 10 minutes in the dark.
Images were taken with a fluorescence confocal microscope.
| Detection of glycogen and lipids
Glycogen staining was performed with a Periodic Acid-Schiff kit (PAS, Sigma-Aldrich, USA), and the amount of glycogen in hiHeps was quantified using a glycogen content assay kit (Solarbio, BC0340, China) according to the manufacturer's instructions. Similarly, lipid staining was performed with an Oil Red O stain kit (Solarbio, G1262, China).
| Uptake of indocyanine green (ICG) and low-density lipoprotein (LDL)
hiHeps were incubated with 5 mg/mL indocyanine green (ICG, J&K, China) in GCM14, GCM14I and HMM at 37°C for 15 minutes. After washing three times with PBS, images of cellular uptake were captured by microscopy. Similarly, hiHeps were incubated with 30 µg/mL Dil-ac-LDL (ANGYUBIO, China) for 5 hours. Then, DAPI (1:100, Invitrogen, USA) was added to the cultures, and the cultures were incubated for 1 hour. Images were taken with a fluorescence microscope.
| Measurement of LDH and ALT activity
The lactate dehydrogenase (LDH) and alanine aminotransferase (ALT) levels in the supernatant were determined by an LDH assay kit-WST (DOJINDO, Japan) and ALT assay kit (Nanjing Jiancheng, China), respectively, according to the manufacturer's instructions.
| Analysis of metabolic activity of UGT1A1
To test UDP-glucuronosyltransferase 1A1 (UGT1A1) activity, hiHeps were incubated with Hank's Balanced Salt Solution (HBSS) containing the indicated drug for 4 hours. The supernatant was collected and measured under a fluorescence microplate reader at wavelengths of 340 and 460 nm.
| Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted from hiHeps using Trizol reagent Table 1 .
| Western Blotting
hiHeps were harvested and lysed with 100 μL protein extraction AUUGCACUCCUCCACUAGCTT-3′) (RiboBio, Guangzhou, China) were used to specifically down-regulate HNF1A in hiHeps, and non-specific sequence siRNAs were used as negative controls (NCs) (RiboBio, China).
Cells that did not undergo transfection served as the control, and cells treated with the transfection reagent were considered mock transfected. After 24 to 48 hours of siRNA transfection, the knockdown efficiency was confirmed by qRT-PCR and Western blot analysis.
| Statistical analysis
The results are shown as the mean ± standard deviation (SD), with at least three separate experiments for each study. Statistical significance was evaluated using one-way ANOVA and the Student's t test when data could be assessed as normally distributed. A value of P < 0.05 was considered statistically significant.
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| hiHeps have poor proliferative capacity in GCM14 medium
Previously, a chemically defined SFM-GCM14 was generated using statistical experimental design. First, the proliferation capacity of hiHeps in GCM14 was investigated. The results
showed that compared with hiHeps cultured in HMM medium, hiHeps cultured in GCM14 have low proliferative capacity within 8 days ( Figure 1A) , and the fold expansion was gradually reduced ( Figure 1B) . As a result of the limited proliferation and expansion in GCM14, it was difficult to support long-term culture and expansion of hiHeps in vitro.
| Effect of insulin on hiHep proliferation and gene expression
As a result of the poor proliferative capacity of hiHeps in GCM14 medium, a strategy of using exogenous growth factors to promote cell proliferation was adopted. Studies have revealed that insulin can promote the proliferation and function of several cell types. [22] [23] [24] [25] In this study, hiHeps were exposed to various concentrations of insulin, rang- Figure 3A) . Then, the showed that insulin significantly increased the protein expression of cyclin D1 compared to that of the control ( Figure 3D ), which showed that cyclin D1 was involved in insulin-induced hiHep proliferation.
In general, the effect of insulin on the promotion of cell proliferation is mainly modulated by protein kinase B1 (Akt1) or extracellular regulated protein kinase (ERK). 31, 32 Therefore, the effect of insulin on the phosphorylation of Akt1 and ERK in hiHeps was investigated.
Insulin treatment significantly increased the level of Akt1 phosphorylation, but the phosphorylation levels of ERK remained unchanged ( Figure 3E ). Together, these findings suggest that insulin promotes the proliferation and viability of hiHeps in GCM14 as effectively as HMM, and this effect occurs as a result of the cyclin D1-mediated G1-S phase progression, which involves increased Akt1 activity.
| Insulin promotes hiHep proliferation via augmented cyclin D1 expression that is mediated by the Akt1/mTOR/p70S6K and Akt1/p53 pathways
To further investigate the possible molecular mechanisms responsible significantly attenuated the insulin-induced increases in p-Akt1, pmTOR, p-p70S6K and cyclin D1 expression levels and increased the expression of p-P53 ( Figure 4B ). Additionally, LY294002 also reduced insulin-stimulated hiHep proliferation ( Figure 4C ). Together, these results suggest that insulin regulates the proliferation of hiHeps through two different mechanisms by increasing the expression of cyclin D1 via the Akt1/mTOR/p70S6K signalling pathway, and by down-regulating the expression of the P53 protein, which inhibits cyclin D1 activity ( Figure 4D ). Both of these mechanisms drive cell cycle progression and promote hiHep proliferation.
| Effect of insulin on the liver function of hiHeps
Previous results have indicated that the addition of 1.0 mg/L insulin to GCM14 significantly promotes hiHep proliferation. However, the harvested cells are also required to have normal liver function. Thus, the effect of insulin on hiHep function was investigated. Albumin and urea are synthesized in the liver, which are important markers that reflect the detoxification function of the liver. 35 The results showed that the synthesis of ALB was increased in hiHeps after the addition of insulin ( Figure 5A ). While the secretion of urea did not increase, but hiHeps had increased urea secretion capacity in SFM, compared with HMM ( Figure 5B ). Next, we found that the consumption of glucose and the production of lactic acid were both increased in GCM14I as effectively as in HMM ( Figure 5C ). Furthermore, the staining and quantitative analysis of glycogen and lipids showed that insulin promotes the synthesis of glycogen and lipids in cells, and hiHeps have a better ability to absorb ICG and transport DiI-labelled ac-LDL in GCM14I than in GCM14 ( Figure 5D ). Generally, ALT and LDH can be used as sensitive indicators of liver function decline. 36 Analysis of ALT and LDH in culture supernatant revealed no noticeable difference after insulin treatment, but the release of ALT and LDH were lower in SFM, which
indicates that hiHeps undergo a low level of cell damage when cultured in SFM ( Figure 5E ). These results suggest that insulin promotes hiHep albumin synthesis, glucose consumption, glycogen synthesis and lipid accumulation. Compared with HMM, hiHeps have increased urea secretion capacity, hepatocyte ICG uptake capacity, ac-LDL transport capacity and undergo low levels of cell damage in GCM14I.
| Insulin increases the expression of ALB and UGT1A1 through HNF1A
ALB is an important plasma protein with antioxidant and detoxification abilities, 37 and UGT1A1 is a critical phase II metabolic 
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Previous studies have demonstrated that insulin plays an important role in promoting the proliferation of various cell types. [22] [23] [24] [25] However, whether insulin regulates the proliferation and function of human hepatocytes, especially transdifferentiated cells, remains poorly understood. Previously, we first screened a serum-free media through Plackett-Burman design, 11 and then obtained a medium that can maintain the growth and function of hiHeps through initial optimization, named GCM14 medium. In this report, our results demonstrated that insulin has an obvious effect on hiHep proliferation and specific liver functions at a concentration of 1.0 mg/L in GCM14 medium. hiHeps were transdifferentiated from human fibroblasts.
Several studies have reported that 10-100 mg/L insulin significantly increased the proliferation of human fibroblasts. 39, 40 However, for the cells obtained by transdifferentiation, our results showed that insulin at 0.5-1.0 mg/L had a significant effect on hiHep proliferation. This was possibly related to the expression of insulin receptors on the cell surface.
In general, the effect of insulin on promoting cell proliferation mainly occurs through the AKT and ERK pathways, and cell proliferation is closely related to the cell cycle. hiHeps were transdifferentiated from fibroblasts, and research has demonstrated that in fibroblasts, insulin-induced ERK activation is necessary for cell proliferation. 41 However, our study showed that insulin increased cyclin D1 and p-Akt1 expression in hiHeps, which was different from that in fibroblasts. Studies have shown that p70S6K or P53
could act as transcription factors that regulate cell proliferation by affecting the expression of cyclin D1. 42, 43 For example, previous studies showed that insulin stimulates goose liver cell growth by activating the PI3K/AKT/mTOR/p70S6K signalling pathway, 14 and
there are also studies indicating that activation of P53 induced liver damage and suppressed the rate of liver cell proliferation. 44 Although there are many studies on the effects of insulin on cell proliferation, the effect of insulin on human hepatocytes, especially on transdifferentiated hepatocytes, has been explored little.
Our results suggest that insulin regulates the proliferation of hi- Insulin has extensive biological effects that regulate cell metabolic function. For example, research has showed that insulin is an important regulator of liver-specific cytochrome P450 gene expression. 16 Other studies have also shown that insulin can promote lipid synthesis, protein synthesis and glycogen synthesis. 13, 15 However, the effect of insulin on the function of human hepatocytes, especially on transdifferentiated cells in SFM has been rarely reported at present.
Our study revealed that transdifferentiated hiHeps have the ability to synthesize and secrete albumin and that insulin promotes hiHep albumin synthesis, glucose consumption, glycogen synthesis and lipid accumulation. Additionally, hiHeps have increased urea secretion capacity, transport capacity and undergo low levels of cell damage in GCM14I compared with those of HMM. These results showed that insulin also affects transdifferentiated cells. However, it is still unclear whether the mechanism through which insulin affects the function of transdifferentiated cells is similar to that of normal cells.
In this study, we found that the mRNA expression levels of ALB, UGT1A1 and the transcription factor HNF1A were increased after 1.0 mg/L insulin treatment. Further, the secretion of ALB in hiHeps was detected by ELISA, and the enzyme activity of UGT1A1 was detected by substrate consumption. These results also showed that F I G U R E 5 Effect of insulin on the liver function of transdifferentiated hiHeps in GCM14. A, The synthesis of ALB in hiHeps by immunofluorescence staining when cultured in GCM14, GCM14I and HMM (green). B, Urea synthesis. C, Glucose consumption and lactate production. D, Glycogen synthesis, lipid synthesis, ICG intake and Dil-ac-LDL transport. E, Activity of ALT and LDH secreted into the supernatant. All data are presented as means ± SD; n = 3 samples per experimental group. *P < 0.05
The effect of insulin on the expression of ALB and UGT1A1. A, Secretion of albumin in cell culture supernatant. B, Enzyme activity of UGT1A1 in hiHeps. C, The protein expression of ALB, UGT1A1 and HNF1A in hiHeps treated with 0, 0.5 and 1.0 mg/L insulin by Western blotting. D, Expression of the abovementioned proteins was measured in hiHeps transfected with siHNF1A. E, qRT-PCR was performed to analyse the level of related genes in hiHeps after transfection. All data are presented as means ± SD; n = 3 samples per experimental group. *P < 0.05, **P < 0.01 insulin increased the expression of ALB and UGT1A1. Research has shown that the expression level of HNF1A is positively correlated with the expression of ALB and UGT1A1 at the mRNA and protein level, 45 and that there are binding sites of HNF1A in the promoter region of the ALB and UGT1A1 genes. 46 Therefore, we have been suggested that insulin may increase the protein expression of ALB and UGT1A1 by affecting the level of HNF1A. We performed the protein level analysis by Western blot analyses and verified the results by down-regulating the expression of HNF1A by siRNA transfection.
The results showed that insulin affected the expression of ALB and UGT1A1 via HNF1A. However, we do not know how insulin regulates the expression of HNF1A, and the literature reports very little F I G U R E 7 The effect of insulin on hiHep proliferation and expression of specific genes during long-term passaging in GCM14I. A, The effect of insulin on hiHep expansion (fold increase) during long-term passage in different culture media and B, cumulative population doubling (CPD). C, Hepatocyte-specific gene expression by semi-qRT-PCR and qRT-PCR analysis. D, Expression of the CYP gene in transdifferentiated hiHeps with or without insulin in GCM14. All data are presented as means ± SD; n = 3 samples per experimental group. *P < 0.05 on this topic. Finally, the results demonstrated that insulin treatment supports hiHep proliferation and stable expression of specific genes during long-term passaging in SFM. Although it is theoretically possible to generate 10 10 functional hiHeps in vitro in GCM14I, when actually culturing these cells, not only is the cost high but it is also difficult to obtain a high enough cell number for a BAL in a short time. Therefore, we need to achieve high-density culture of hiHeps in serum-free GCM14I, including microcarrier culture and three-dimensional perfusion culture, which will create a solid basis for the clinical application of hiHep-BALs.
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